Nonoperating Income (Expense) in USD of VOLITIONRX LTD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
VOLITIONRX LTD quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2014 to Q1 2024.
  • VOLITIONRX LTD Nonoperating Income (Expense) for the quarter ending 31 Mar 2024 was -$87.5K, a 151% decline year-over-year.
  • VOLITIONRX LTD Nonoperating Income (Expense) for the twelve months ending 31 Mar 2024 was $51K, a 96.3% decline year-over-year.
  • VOLITIONRX LTD annual Nonoperating Income (Expense) for 2023 was $311K, a 73.7% decline from 2022.
  • VOLITIONRX LTD annual Nonoperating Income (Expense) for 2022 was $1.18M, a 12% decline from 2021.
  • VOLITIONRX LTD annual Nonoperating Income (Expense) for 2021 was $1.34M, a 58.3% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

VOLITIONRX LTD Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $51K -$87.5K -$260K -151% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $311K -$59.1K -$734K -109% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2024
Q3 2023 $1.04M $200K +$19.2K +10.6% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $1.03M -$2.24K -$370K -101% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $1.39M $172K +$213K 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $1.18M $674K -$2.32K -0.34% 01 Oct 2022 31 Dec 2022 10-K 25 Mar 2024
Q3 2022 $1.18M $181K -$200K -52.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $1.38M $367K +$41.3K +12.7% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $1.34M -$41K -$570 -1.41% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $1.34M $677K +$179K +35.8% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2022
Q3 2021 $1.16M $381K +$212K +126% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $952K $326K +$157K +92.7% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 $796K -$40.5K -$53K -422% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $849K $498K +$331K +197% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $518K $168K +$173K 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $345K $169K +$173K 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021
Q1 2020 $172K $12.6K +$228K 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 -$56.1K $168K 01 Oct 2019 31 Dec 2019 10-K 22 Mar 2021
Q3 2019 -$4.66K 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$3.66K 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 -$215K 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q1 2014 -$956K 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014

VOLITIONRX LTD Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $311K -$871K -73.7% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2024
2022 $1.18M -$162K -12% 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2024
2021 $1.34M +$495K +58.3% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2022
2020 $849K +$905K 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 -$56.1K +$54.8K +49.4% 01 Jan 2019 31 Dec 2019 10-K 22 Mar 2021
2018 -$111K 01 Jan 2018 31 Dec 2018 10-K 20 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.